Abstract
Overexpression of somatostatin receptors has been demonstrated in various brain tumours such as meningiomas or glia-derived tumours. This evidence, following the clinical experience on neuroendocrine tumours, suggests that somatostatin analogues may also be of value for the imaging and treatment of the above-mentioned brain neoplasms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartolomei M, Bodei L, De Cicco C, et al. Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma. Eur J Nucl Med Mol Imaging. 2009;36:1407–16.
Schumacher T, Hofer S, Eichhorn K, et al. Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging. 2002;29:486–93.
Suggested Reading
Reardon DA, Rich JN, Friedman HS, et al. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol. 2006;24:1253–65. Review.
Zalutsky MR. Current status of therapy of solid tumors: brain tumour therapy. J Nucl Med. 2005;46:151S–6. Review.
Zoller F, Eisenhut M, Haberkorn U, et al. Endoradiotherapy in cancer treatment – basic concepts and future trends. Eur J Pharmacol. 2009;625:55–62. Review.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Agostini, M., Casi, M., De Lauro, F., Mattone, V., Bartolomei, M. (2011). Brain Imaging with SPECT-CT. In: Atlas of SPECT-CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15726-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-15726-4_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15725-7
Online ISBN: 978-3-642-15726-4
eBook Packages: MedicineMedicine (R0)